GNAS and hepatocellular carcinoma: This notion was also supported by the following finding: As seen in Figure 3A–F and Figure 4A–D, in patients at different stages of transition from chronic liver diseases to HCC, the autoantibody to GNAS in level and frequency gradually increased from CC through DC to HCC and reached the peak at the early HCC stage.